![Richard Peters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Peters
Presidente presso
APREA THERAPEUTICS, INC.
Patrimonio netto: 212 659 $ in data 31/05/2026
Profilo
Richard Peters was the founder of X4 Pharmaceuticals, Inc. (2014), X4 Pharmaceuticals, Inc. (2010), MedNav, Inc. (1997) where the title held was Chief Executive Officer, and PIC Therapeutics, Inc. (2016) where the title held was Director.
Dr. Peters is also the founder of Tellbio, Inc. Dr. Peters is currently the President, Chief Executive Officer & Director at Yumanity, Inc., Chairman at Pharming Group NV since 2023, and Chairman at Aprea Therapeutics, Inc. since 2020.
Former positions include President, Chief Executive Officer & Director at Merrimack Pharmaceuticals, Inc. (2017-2019), President, CEO, Secretary, Treasurer & Director at Yumanity Therapeutics, Inc. (2020-2022), Director-Medical Affairs at Amgen, Inc. (2003-2006), Senior Director at Onyx Pharmaceuticals, Inc. (2006-2008), Lead Independent Director at Kineta, Inc. (2022-2025), and Senior Vice President & Head-Global Rare Diseases at Genzyme Corp.
(2008-2017).
Education includes a doctorate from The Medical University of South Carolina and an undergraduate degree from College of Charleston.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
PHARMING GROUP NV 0,02% | 28/05/2026 | 156.186 ( 0,02% ) | 209 873 $ | 31/05/2026 |
| 16/06/2026 | 3.119 ( 0,03% ) | 2 785 $ | 31/05/2026 |
Posizioni attive di Richard Peters
| Società | Posizione | Inizio |
|---|---|---|
| APREA THERAPEUTICS, INC. | Presidente | 23/08/2023 |
| PHARMING GROUP N.V. | Presidente | 25/09/2023 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Amministratore Delegato | - |
Tellbio, Inc.
 Tellbio, Inc. BiotechnologyHealth Technology Engages in biotechnology business | Fondatore | - |
Precedenti posizioni note di Richard Peters
| Società | Posizione | Fine |
|---|---|---|
| KINETA, INC. | Direttore/Membro del Consiglio | 30/06/2025 |
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Fondatore | 01/06/2022 |
| YUMANITY THERAPEUTICS | Amministratore Delegato | 01/01/2022 |
| MERRIMACK PHARMACEUTICALS | Amministratore Delegato | 28/06/2019 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/01/2017 |
Formazione di Richard Peters
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
77
Relazioni di 1° grado
16
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and distributes oral small molecule CXCR4 antagonists | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Medical University of South Carolina
 Medical University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
College of Charleston
 College of Charleston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedNav, Inc.
 MedNav, Inc. Packaged SoftwareTechnology Services Develops mobile health applications | Technology Services |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Tellbio, Inc.
Tellbio, Inc. BiotechnologyHealth Technology Engages in biotechnology business | Health Technology |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kineta, Inc.
 Kineta, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
